Company / Debt per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Debt per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$3.99
FY2022
5-year range
$3.99 / $4.39
FY2018-FY2022
Trend
-9.0%
vs FY2021
Sector context
#74 of 98
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s debt per share of $3.99 is lower than 76% of companies in the Health Care sector (FY2022). Increased from $0.10 to $3.99 over the past 3 years.
Based on SEC 10-K filings.
3.99 in FY2022 with a 5-year CAGR of +93.5%.
Increased from $0.10 to $3.99 over the past 3 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +237.3%
- 5-Year CAGR
- +93.5%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 98This company $3.99 Sector average $46.19
▼
-91.4% below sector average
Key checks
Key Insights
- In FY2022, debt per share decreased 9.0% year-over-year.
- Ranks #74 out of 98 companies in the Health Care sector.
- Peak debt per share was recorded in FY2021.
- Lowest debt per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $3.99 | -9.0% |
| FY2021 | $4.39 | - |
| FY2020 | - | - |
| FY2019 | $0.10 | -17.5% |
| FY2018 | $0.13 | -14.3% |
| FY2017 | $0.15 | -26.9% |
| FY2016 | $0.20 | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026